/
/
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
This content is Free Access.
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
1,987 Views
•
05:22 min
•
February 24, 2023
DOI:
1Division of Oncology,Children’s Hospital of Philadelphia, 2Center for Data Driven Discovery in Biomedicine,Children’s Hospital of Philadelphia, 3Division of Neurosurgery,Children’s Hospital of Philadelphia, 4Ben Towne Center for Childhood Cancer Research,Seattle Children’s Research Institute, 5Department of Pediatrics, Seattle Children’s Hospital,University of Washington
Summary
Automatically generated
Central nervous system (CNS) tumors are the leading cause of cancer-related death in children, and locoregional immune-based therapies are increasingly being tested for patients in clinical trials. This protocol describes methods for locoregional cannula implantation in mice for the preclinical evaluation of immunotherapeutic infusions targeting CNS tumors.
Read Article
Cite this Article
Harvey, K., Madsen, P. J., Smith, T., Griffin, C., Patterson, L., Vitanza, N. A., Storm, P. B., Resnick, A. C., Foster, J. B. Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice. J. Vis. Exp. (192), e64886, doi:10.3791/64886 (2023).
Copy